Amyloidosis cutis dyschromica: A case treated with acitretin

Journal of Dermatology

Volumn 32, Issue 6, 2005, Pages 474-477

  Ozcan, Atilla ^a   Senol, Mustafa ^a   Aydin, Nasuhi Engin ^b   Karaca, Semsettin ^a  

^a INONU UNIVERSITY   (Turkey)

^b Department of Pathology ^*  (Turkey)

Author keywords

Amyloidosis cutis dyschromica; Vitiliginous amyloidosis

Indexed keywords

ETRETIN;

ADULT; AMYLOIDOSIS; AMYLOIDOSIS CUTIS DYSCHROMICA; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; HYPOPIGMENTATION; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; SKIN INFLAMMATION; TREATMENT OUTCOME;

EID: 22344456060     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00783.x     Document Type: Article

References (16)

1. Wang WJ, Chang YT, Huang CY, Lee DD: Clinical and histopathological characteristics of primary cutaneous amyloidosis in 794 Chinese patients, Zhonghua Yi Xue Za Zhi (Taipei), 64: 101-107, 2001.
2. Eswaramoorthy V, Kaur I, Das A, Kumar B: Macular amyloidosis: Etiological factors, J Dermatol, 26: 305-310, 1999.
3. Moriwaki S, Nishigori C, Horiguchi Y, et al: Amyloidosis cutis dyschromica, Arch Dermatol, 128: 966-970, 1992.
4. Morishima T: Amyloidosis cutis dyschromica, Dermatol Clin, 3: 627-630, 1981.
5. Choonhakarn C, Wittayachanyapong S: Familial amyloidosis cutis dyschromica: Six cases from three families, J Dermatol, 29: 439-442, 2002.
6. Vijaikumar M, Thappa DM: Amyloidosis cutis dyschromica in two siblings, Clin Exp Dermatol, 26: 674-676, 2001.
7. Furumoto H, Shimizu T, Asagami C, et al: Apolipoprotein E is present in primary localized cutaneous amyloidosis, J Invest Dermatol, 111: 417-421, 1998.
8. Chang YT, Liu HN, Wong CK, Chow KC, Chen KY: Detection of Epstein-Barr virus in primary cutaneous amyloidosis, Br J Dermatol, 136: 823-826, 1997.
9. Al-Ratrout JT, Satti MB: Primary localized cutaneous amyloidosis: a clinicopathologic study from Saudi Arabia, Int J Dermatol, 36: 428-434, 1997.
10. Macsween RM, Saihan EM: Nylon cloth macular amyloidosis, Clin Exp Dermatol, 22: 28-29, 1997.
11. Ortiz-Romero PL, Ballestin-Carcavilla C, Lopez-Estebanz JL, Iglesiaz-Diez L: Clinicopathologic and histochemical studies on lichen amyloidosis and macular amyloidosis, Arch Dermatol, 130: 1559-1560, 1994.
12. Huilgol SC, Ramnarain N, Carrington P, Leigh IM, Black MM: Cytokeratins in primary cutaneous amyloidosis, Australas J Dermatol, 39: 81-85, 1998.
13. Lucas S: Primary cutaneous amyloidosis (reply), Tropical Doctor, 32: 57, 2002.
14. Westermark P, Ridderström E, Vahlquist A: Macular posterior pigmentary incontinence: Its relation to macular amyloidosis and notalgia paresthetica, Acta Derm Venereol, 76: 302-304, 1996.
15. Ozkaya Bayazit E, Kavak A, Gungor H, Ozarmagan G: Intermittent use of topical dimethyl sulfoxide in macular and papular amyloidosis, Int J Dermatol, 37: 949-954, 1998.
16. Marschalko M, Daroczy J, Soos G: Etretinate for the treatment of lichen amyloidosis, Arch Dermatol, 124: 657-659, 1988.